Hsp47 (SERPINH1) Human shRNA Plasmid Kit (Locus ID 871)
CAT#: TL316478
SERPINH1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
Cited in 1 publication. |
CNY 4,070.00
Specifications
Product Data | |
Product Name | Hsp47 (SERPINH1) Human shRNA Plasmid Kit (Locus ID 871) |
Locus ID | 871 |
UniProt ID | P50454 |
Synonyms | AsTP3; CBP1; CBP2; gp46; HSP47; OI10; PIG14; PPROM; RA-A47; SERPINH2 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | SERPINH1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 871). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_001207014, NM_001235, NM_004353, NM_001235.1, NM_001235.2, NM_001235.3, NM_001207014.1, BC070087, BC070087.1, BC014623, BC036298, NM_001207014.2, NM_001235.5 |
Summary | This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The encoded protein is localized to the endoplasmic reticulum and plays a role in collagen biosynthesis as a collagen-specific molecular chaperone. Autoantibodies to the encoded protein have been found in patients with rheumatoid arthritis. Expression of this gene may be a marker for cancer, and nucleotide polymorphisms in this gene may be associated with preterm birth caused by preterm premature rupture of membranes. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 9. [provided by RefSeq, May 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling via PHLPP1 in colorectal cancer
,Chern, Y;Zhang, P;Ju, H;Tai, IT;,
Cancer Biol Med
,PubMed ID 32587773
[SERPINH1]
|
Documents
Product Manuals |
FAQs |
SDS |
其它SERPINH1产品